Merit Financial Group’s Roivant Sciences ROIV Stock Holding History
Bought
Maintained
Sold
Other funds holding ROIV
PDM
CA
ETC
SEIA
LSERS
YCM
YIH
COPPSERS
Merit Financial Group's ROIV Position: Q2 2026 in Review
Merit Financial Group reduced its Roivant Sciences (ROIV) stake by 3.6% in Q2 2026, selling an estimated $15.6K and leaving 14,285 shares worth $506K. The position accounts for ﹤0.01% of the portfolio, ranked #1487.
Merit Financial Group first reported a position in ROIV in Q1 2026 and has held it in 2 quarters since. 65 funds tracked by Wall St. Rank hold ROIV as of Q2 2026.
- Merit Financial Group held 14,285 shares of Roivant Sciences worth $506K as of Q2 2026.
- Merit Financial Group sold 528 Roivant Sciences shares in Q2 2026, an estimated $15.6K.
- Roivant Sciences made up ﹤0.01% of Merit Financial Group's portfolio in Q2 2026, its #1487 holding.
- Merit Financial Group first reported a position in Roivant Sciences in Q1 2026 and has held it in 2 quarters since.
- 65 funds tracked by Wall St. Rank held Roivant Sciences as of Q2 2026.
Based on Merit Financial Group's 13F filing for Q2 2026, filed 17 Jul 2026.